Paul FARMER, USA

Paul Farmer, M.D., Ph.D., is the Maude and Lillian Presley Professor of Medical Anthropology at Harvard Medical School and Medical Director of the Clinique Bon Sauveur, a charity hospital in rural Haiti. An infectious disease physician as well as anthropologist, Dr. Farmer has worked in communicable-disease control in the Americas for over a decade. Along with his colleagues in the Program in Infectious Disease and Social Change in the Department of Social Medicine at Harvard Medical School, Dr. Farmer has pioneered novel, community-based treatment strategies for tuberculosis—and also sexually transmitted infections (including HIV) and drug-resistant typhoid—in resource-poor settings. Dr. Farmer is Vice Chief of Brigham and Women’s Hospital’s Division of Social Medicine and Health Inequalities.

Adrian HILL, UK

Professor Adrian V. S. Hill is a Wellcome Trust Principal Research Fellow at the Institute of Molecular Medicine and Wellcome Trust Centre for Human Genetics at the University of Oxford. He qualified for Oxford Clinical School in 1982 and undertook a DPhil in human population genetics at the MRC Molecular Haematology Unit. Following clinical training, he returned to Oxford in 1988 to the Institute of Molecular Medicine. With collaborators in Africa and Asia he has made contributions to the genetics of susceptibility to several infectious diseases, especially malaria and tuberculosis, and to vaccine design and development. His group has recently been undertaking clinical trials of new T cell-inducing malaria vaccines. He is a Fellow of the Royal College of Physicians and of the UK Academy of Medical Sciences.

Rino RAPPUOLI, Italy

Rino Rappuoli is responsible for Chiron Vaccines Research. After earning his PhD in Biological Sciences from the University of Siena, he studied at Washington University of St. Louis, Rockefeller University and Harvard Medical School. He is recipient of the Paul Ehrlich Prize and other prestigious awards and has authored or co-authored 257 original papers, 42 reviews, 31 chapters, and 97 congress proceedings and eight edited volumes. His field of expertise is vaccines, bacterial pathogenesis, and infectious diseases. Dr. Rappuoli is member of several international societies and committees, including the European Molecular Biology Organization; R&D working group of the European Vaccines Manufacturers; Scientific Committee of the Paul Ehrlich Foundation; and External Advisory Group for "Control of Infectious Diseases" of the European Union. He is co-chairman of the R/D Task Force of the Global Alliance for Vaccines and Immunization (GAVI).